Diffuse large B-cell lymphoma

Ask MedXY AI

Latest news

Tag

Hematology-OncologyTumor immune microenvironmentprognostic biomarkers

Decoding the Tumor Immune Microenvironment in Diffuse Large B-Cell Lymphoma: Prognostic Insights from CD163 and CD11c Profiling

By MedXY|Aug 11, 2026

This study identifies distinct tumor immune microenvironment subgroups in diffuse large B-cell lymphoma based on CD163 and CD11c expression, revealing prognostic significance and potential therapeutic stratification with checkpoint inhibito

$Ultralow-Dose IL-10–Expressing CAR T Cells Show Promising Activity in Relapsed/Refractory DLBCL$

Hematology-OncologyCAR T-cell therapyDiffuse large B-cell lymphoma

Ultralow-Dose IL-10–Expressing CAR T Cells Show Promising Activity in Relapsed/Refractory DLBCL

By MedXY|Jul 25, 2026

A phase 1 trial of ultralow-dose IL-10–expressing CD19 CAR T cells in 13 patients with R/R DLBCL reported a 92.3% objective response rate with manageable safety.